170 related articles for article (PubMed ID: 32951246)
1. Comparison between a new thyroglobulin assay with the well-established Beckman Access immunoassay: A preliminary report.
Cennamo M; La Civita E; Curci A; Liotti A; Braschi U; Terracciano D
J Clin Lab Anal; 2021 Feb; 35(2):e23589. PubMed ID: 32951246
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of thyroglobulin measurement with fine-needle aspiration biopsy for lymph node metastases in patients with a history of differentiated thyroid cancer.
Zhang HS; Wang RJ; Fu QF; Gao S; Sun BT; Sun H; Ma QJ
Asian Pac J Cancer Prev; 2014; 15(24):10905-9. PubMed ID: 25605199
[TBL] [Abstract][Full Text] [Related]
3. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
[TBL] [Abstract][Full Text] [Related]
4. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
[TBL] [Abstract][Full Text] [Related]
5. Cervical Lymph Node Fine-Needle Aspiration and Needle-Wash Thyroglobulin Reflex Test for Papillary Thyroid Carcinoma.
Zhang X; Howell JM; Huang Y
Endocr Pathol; 2018 Dec; 29(4):346-350. PubMed ID: 30203321
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures.
Giovanella L; Ceriani L; Ghelfo A; Keller F; Sacchi A; Maffioli M; Spriano G
Clin Chem Lab Med; 2006; 44(5):648-52. PubMed ID: 16681439
[TBL] [Abstract][Full Text] [Related]
8. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma.
Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA
Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.
Stanojevic M; Savin S; Cvejic D; Djukic A; Jeremic M; Zivancević Simonovic S
J Clin Lab Anal; 2009; 23(5):341-6. PubMed ID: 19774624
[TBL] [Abstract][Full Text] [Related]
10. Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.
Jo K; Kim MH; Lim Y; Jung SL; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
Eur J Endocrinol; 2015 Oct; 173(4):489-97. PubMed ID: 26208979
[TBL] [Abstract][Full Text] [Related]
11. Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.
Spencer C; Petrovic I; Fatemi S; LoPresti J
J Clin Endocrinol Metab; 2014 Dec; 99(12):4589-99. PubMed ID: 25226290
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
[TBL] [Abstract][Full Text] [Related]
13. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
[TBL] [Abstract][Full Text] [Related]
14. Multicentre clinical evaluation of the new highly sensitive Elecsys® thyroglobulin II assay in patients with differentiated thyroid carcinoma.
Trimboli P; Imperiali M; Piccardo A; CampennÌ A; Giordani I; Ruggeri RM; Baldari S; Orlandi F; Giovanella L
Clin Endocrinol (Oxf); 2018 Feb; 88(2):295-302. PubMed ID: 28960391
[TBL] [Abstract][Full Text] [Related]
15. Influence of thyroid gland status on the thyroglobulin cutoff level in washout fluid from cervical lymph nodes of patients with recurrent/metastatic papillary thyroid cancer.
Lee JH; Lee HC; Yi HW; Kim BK; Bae SY; Lee SK; Choe JH; Kim JH; Kim JS
Head Neck; 2016 Apr; 38 Suppl 1():E1705-12. PubMed ID: 26614648
[TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin in differentiated thyroid cancer.
Evans C; Tennant S; Perros P
Clin Chim Acta; 2015 Apr; 444():310-7. PubMed ID: 25444737
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of a new highly sensitive thyroglobulin immunoassay.
Iervasi A; Iervasi G; Bottoni A; Boni G; Annicchiarico C; Di Cecco P; Zucchelli GC
J Endocrinol; 2004 Aug; 182(2):287-94. PubMed ID: 15283689
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
Giovanella L; Imperiali M; Verburg FA; Ceriani L
Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer.
Giovanella L; Bongiovanni M; Trimboli P
Curr Opin Oncol; 2013 Jan; 25(1):6-13. PubMed ID: 23090642
[TBL] [Abstract][Full Text] [Related]
20. Do thyroid cancer patients with basal undetectable Tg measured by current immunoassays require rhTSH testing?
Díaz-Soto G; Puig-Domingo M; Martínez-Pino I; Martínez de Osaba MJ; Mora M; Rivera-Fillat F; Halperin I
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):348-52. PubMed ID: 21264807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
